Navigation Links
Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization
Date:11/11/2009

cense Application (BLA) for PROVENGE® (sipuleucel-T) to the U.S. Food and Drug Administration (FDA).
  • Elected Ian Clark and Pedro Granadillo to Board of Directors. Beginning Jan. 1, Mr. Clark will be chief executive officer and head of North American commercial operations at Genentech, a wholly-owned member of the Roche Group. Mr. Granadillo was most recently senior vice president of global manufacturing and human resources at Eli Lilly & Company.
  • "Submitting our BLA amendment is a milestone achievement for the organization," stated Mitchell H. Gold, M.D., president and chief executive officer of Dendreon Corporation. "We look forward to working with the FDA to make PROVENGE available as quickly as possible to the many men who currently have few appealing treatment options."

    Conference Call Information

    Dendreon will host a conference call today at 1:30 p.m. PT, 4:30 p.m. ET. To access the live call, dial 1-888-516-2435 (domestic) or +1-719-457-2626 (international). The call will also be audio webcast and will be available from the Company's website at www.dendreon.com under the "Investor/Webcasts and Presentations" section. A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-888-203-1112 or +1-719-457-0820 for international callers; the conference ID number is 5275498. The replay will be available from 6:30 pm ET on Wednesday, November 11, until 11:59 pm ET on Friday, November 13. In addition, the webcast will be archived for on-demand listening for 30 days at www.dendreon.com.

    About PROVENGE

    PROVENGE is Dendreon's investigational product candidate for men with advanced prostate cancer and may represent the first in a new class of active cellular immunotherapies (ACIs) specifically designed to engage the patient's own
    '/>"/>

    SOURCE Dendreon Corporation
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. Dendreon Completes Submission of Biologics License Application for PROVENGE
    2. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
    3. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
    4. Dendreon Announces Analyst Day Webcast Presentation to be Held on September 24, 2009
    5. Dendreon Reports Second Quarter 2009 Financial Results
    6. Dendreon Signs Lease for New Manufacturing Facility in Atlanta
    7. Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET
    8. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
    9. Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest
    10. Dendreon Announces Closing of Common Stock Offering
    11. Dendreon Announces Common Stock Offering
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/11/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its ... TECHNOLOGY: GLOBAL MARKETS , the global market for digital ... in 2013. This is estimated to grow to $490 ... rate (CAGR) of 28.6%. , New digital PCR technology ... within the broader PCR field. The opportunities presented by ...
    (Date:7/11/2014)... -- Researchers have pioneered a revolutionary new way to ... Virtual Finger, allows scientists to move through digital ... using the flat surface of their computer screens. ... orders of magnitude more efficient, saving time, money ... areas of experimental biology. The software and its ...
    (Date:7/10/2014)... (PRWEB) July 10, 2014 Product ... in very low abundance and are often “lost ... and time-consuming. , Join presenters Dr. Rowel Tobias, ... Dr. John Anders, Head of Quality at Nanotherapeutics, ... approach that can speed detection and quantitation while ...
    (Date:7/10/2014)... Mass. (PRWEB) July 10, 2014 Terascala, ... today announced that Alan Swahn, a former vice president ... executive team as vice president of marketing. Terascala’s software ... Dell and NetApp create the highest performance and most ... been appointed to guide Terascala’s channel expansion and broaden ...
    Breaking Biology Technology:Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Terascala Expands Executive Team 2Terascala Expands Executive Team 3
    ... Biotherapeutics Holdings Corp. (NASDAQ: TLCR ) will issue ... April 27, 2011. Due to the pending merger with Grifols, ... discuss its first quarter results. About Talecris ... Talecris Biotherapeutics is a global biotherapeutic and biotechnology company ...
    ... 14, 2011 QRxPharma Limited (ASX: QRX ... Patent and Trademark Office (USPTO) issued the Company a ... This patent covers a proprietary dosing algorithm for converting ... IR, thereby more effectively and safely managing acute pain ...
    ... April 14, 2011 Reportlinker.com announces that ... in its catalogue: Neurology ... – Neurostimulation Devices, Interventional Neurology and Other ... Neurology Devices Market Outlook in China ...
    Cached Biology Technology:U.S. Patent and Trademark Office (USPTO) Issues QRxPharma a New Patent for MoxDuo® IR; Extends Patent Coverage to 2029 2U.S. Patent and Trademark Office (USPTO) Issues QRxPharma a New Patent for MoxDuo® IR; Extends Patent Coverage to 2029 3Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 2Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 3Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 4Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 5Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 6Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 7Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 8Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 9Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 10Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 11Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 12Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other 13
    (Date:7/10/2014)... -- Unisys Corporation,s (NYSE: UIS ) subsidiary in ... that it has been selected by the Dutch Custodial Institutions ... Provision Biometrics solution for penitentiaries across The Netherlands ... a solution based on its open standards-based LEIDA ... is up to seven years, with the new system expected ...
    (Date:7/10/2014)... July 3, 2014 Research and Markets ... the "Global Gesture Recognition & Touch-Less Sensing ... to 2020" report to their offering ... Gesture Recognition & Touch-Less Sensing Market to Grow ... a while, but the companies were unable to ...
    (Date:7/10/2014)... Intelligence today released forecasts from "The Global National eID ... for National Electronic ID (eID) programs will generate $54 billion ... number of National eID cards in circulation will double from ... with its vast population, will dominate the market representing nearly ... Europe trails a distant second at 11%. ...
    Breaking Biology News(10 mins):Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 3Global Gesture Recognition & Touch-Less Sensing (2D, 3D, Ultrasonic, IR, Capacitive) Market - Forecasts to 2020 2National Electronic ID Programs Generate $54 Billion Between 2013 and 2018 with 3.5 Billion National eID Card Holders Worldwide 2
    ... people around the world being sick doesn,t mean making a ... Nyquil. Instead it means turning to the forest to ... aches to chest pains. But while questions persist ... pharmacological cousins, one Harvard researcher is examining the phenomenon from ...
    ... July 30, 2012 In the years after Columbus, voyage, ... a phenomenon some have attributed to decimation of native populations ... suggests global cooling resulted in fewer fires because both preceded ... [after about A.D. 1500] has been linked previously to the ...
    ... China A five-country international team, led by Casey ... School of Medicine First Affiliated Hospital identified the NMNAT1 ... one of the most common causes of inherited blindness ... Nature Genetics , reporting the genetic characteristics underlying ...
    Cached Biology News:Health care savings, naturally 2Health care savings, naturally 3When the world burned less 2When the world burned less 3When the world burned less 4When the world burned less 5BGI reports the latest finding on NMNAT1 mutations linked to Leber congenital amaurosis 2
    Multidrop Micro high speed 1 l bulk reagent dispenser rapidly, precisely and accurately dispenses microvolumes of 1-50 l into 384- and 96-well microplates....
    ...
    ...
    Buckets for tube holder inserts...
    Biology Products: